A. Prat

[Vaccines against varicella-zoster virus (VZV)].

M. Salleras, N. Soldevila, Á. Domínguez, 2015, Enfermedades infecciosas y microbiologia clinica.

Herpes zoster and postherpetic neuralgia in Catalonia (Spain)

M. Salleras, N. Soldevila, Á. Domínguez, 2014 .

Cost-benefit and cost-effectiveness of the incorporation of the pneumococcal 7-valent conjugated vaccine in the routine vaccination schedule of Catalonia (Spain).

Á. Domínguez, L. Salleras, L. Salleras, 2005, Vaccine.

Contacts with children and young people and adult risk of suffering herpes zoster.

M. Salleras, N. Soldevila, N. Torner, 2011, Vaccine.

Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.

Á. Domínguez, L. Salleras, L. Salleras, 2007, Vaccine.

Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.

Á. Domínguez, L. Salleras, M. Bruguera, 2005, Vaccine.

Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study.

T. Pumarola, E. Carreras, J. Oller, 2006, Vaccine.

Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children

N. Soldevila, N. Torner, Á. Domínguez, 2013, Human vaccines & immunotherapeutics.

Low reactogenicity of the virosomal subunit influenza vaccine in healthy children without risk factors

T. Pumarola, E. Carreras, J. Oller, 2009 .